These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2688680)

  • 1. Thrombosis in atherogenesis.
    Kaplan KL; Bini A
    Crit Rev Oncol Hematol; 1989; 9(4):305-18. PubMed ID: 2688680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
    Bini A; Fenoglio JJ; Mesa-Tejada R; Kudryk B; Kaplan KL
    Arteriosclerosis; 1989; 9(1):109-21. PubMed ID: 2643421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin and the vessel wall.
    Kaplan KL; Bini A; Fenoglio J; Kudryk B
    Adv Exp Med Biol; 1990; 281():313-8. PubMed ID: 2102620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
    Smith EB
    Clin Haematol; 1986 May; 15(2):355-70. PubMed ID: 3524931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells].
    Naito M
    Nihon Ronen Igakkai Zasshi; 2000 Jun; 37(6):458-63. PubMed ID: 10998926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions.
    Bini A; Fenoglio J; Sobel J; Owen J; Fejgl M; Kaplan KL
    Blood; 1987 Apr; 69(4):1038-45. PubMed ID: 2950941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis.
    Naito M; Stirk CM; Smith EB; Thompson WD
    Thromb Res; 2000 Apr; 98(2):165-74. PubMed ID: 10713318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen/fibrin in atherogenesis.
    Smith EB; Thompson WD; Crosbie L; Stirk CM
    Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
    Smith EB
    Thromb Res; 1994 Aug; 75(3):329-35. PubMed ID: 7992244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
    Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
    Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products.
    Thompson WD; Smith EB; Stirk CM; Kochhar A
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):489-93. PubMed ID: 1723306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of fibrinogen in human arterial intima.
    Smith EB; Keen GA; Grant A; Stirk C
    Arteriosclerosis; 1990; 10(2):263-75. PubMed ID: 2317160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic risk factors for atherosclerosis.
    Dobroski DR; Loscalzo J
    Coron Artery Dis; 1996 Dec; 7(12):919-32. PubMed ID: 9116935
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.
    Xiao Q; Danton MJ; Witte DP; Kowala MC; Valentine MT; Degen JL
    J Clin Invest; 1998 Mar; 101(5):1184-94. PubMed ID: 9486990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen and fibrin in the arterial wall.
    Bini A; Kudryk BJ
    Thromb Res; 1994 Aug; 75(3):337-41. PubMed ID: 7992245
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen, fibrin and the arterial wall.
    Smith EB
    Eur Heart J; 1995 Mar; 16 Suppl A():11-4; discussion 14-5. PubMed ID: 7796823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen and atherosclerosis.
    Smith EB
    Wien Klin Wochenschr; 1993; 105(15):417-24. PubMed ID: 8379153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apo B, fibrinogen-fibrin and fibronectin in the intima of the normal human aorta and large arteries and in atherosclerosis].
    Shekhonin BV; Tararak EM; Samokhin GP; Vinogradov DV; Kotelianskiĭ VE
    Arkh Patol; 1990; 52(4):16-21. PubMed ID: 2201275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
    Kroneman H; Nieuwenhuizen W; Knot EA
    Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The localization of tissue factor and apolipoprotein(a) in atherosclerotic lesions of the human aorta and their relation to fibrinogen-fibrin transition.
    Ichikawa K; Nakagawa K; Hirano K; Sueishi K
    Pathol Res Pract; 1996 Mar; 192(3):224-32. PubMed ID: 8739469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.